Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Targeting tumor cells through the generation of reactive oxygen species (ROS) is a therapeutic strategy that exploits the unique redox biology of cancer. It aims to elevate intratumoral ROS above the cytotoxic threshold, leveraging the fact that cancer cells are often near their maximum tolerable oxidative stress level. This can be achieved by boosting intracellular oxidants or disabling antioxidant defenses. This approach leverages fundamental differences between cancerous and healthy tissues' redox homeostasis for selective therapy development.
Increase intratumoral ROS above cytotoxic threshold by either boosting intracellular oxidants or disabling antioxidants.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cells via Generation of Reactive Oxygen Species (None).